Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rüdiger Hehlmann

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Haematologica|March 3, 2017
Research in the heart of hematology: chronic myeloid leukemia 2017Rüdiger Hehlmann
Blood|June 2, 2012
How I treat CML blast crisisRüdiger Hehlmann
Haematologica|June 3, 2016
Innovation in hematology. Perspectives: CML 2016Rüdiger Hehlmann
Blood|November 11, 2017
Prognostic relevance of CCAs/Ph<sup>-</sup> in CML settledRüdiger Hehlmann
British Journal of Haematology|July 1, 2021
What is the right dosage of dasatinib for treating chronic myeloid leukaemia?Rüdiger Hehlmann
Annals of Hematology|March 28, 2015
CML--Where do we stand in 2015?Rüdiger Hehlmann
Journal of Clinical Medicine|November 19, 2020
The New ELN Recommendations for Treating CMLRüdiger Hehlmann
Cancer|February 17, 2018
Advancing a field by building consortia: The example of the European LeukemiaNetRüdiger Hehlmann
European Journal of Haematology|December 9, 2015
CML - we are not there yetRüdiger Hehlmann
Hemasphere|November 2, 2020
Chronic Myeloid Leukemia in 2020Rüdiger Hehlmann
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Haematologica|March 3, 2017
Research in the heart of hematology: chronic myeloid leukemia 2017Rüdiger Hehlmann
Blood|June 2, 2012
How I treat CML blast crisisRüdiger Hehlmann
Haematologica|June 3, 2016
Innovation in hematology. Perspectives: CML 2016Rüdiger Hehlmann
Blood|November 11, 2017
Prognostic relevance of CCAs/Ph<sup>-</sup> in CML settledRüdiger Hehlmann
British Journal of Haematology|July 1, 2021
What is the right dosage of dasatinib for treating chronic myeloid leukaemia?Rüdiger Hehlmann
Annals of Hematology|March 28, 2015
CML--Where do we stand in 2015?Rüdiger Hehlmann
Journal of Clinical Medicine|November 19, 2020
The New ELN Recommendations for Treating CMLRüdiger Hehlmann
Cancer|February 17, 2018
Advancing a field by building consortia: The example of the European LeukemiaNetRüdiger Hehlmann
European Journal of Haematology|December 9, 2015
CML - we are not there yetRüdiger Hehlmann
Hemasphere|November 2, 2020
Chronic Myeloid Leukemia in 2020Rüdiger Hehlmann
Pageof 14